{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": "Liu_et_al.__2024_",
  "verified_evidence": [
    {
      "id": 1,
      "quote": "The manufacturing process can lead to egg adapted mutations in the hemagglutinin (HA) protein in IIV, that could result in altered antigenicity and reduced vaccine effectiveness (VE) in the population.",
      "supports_claim": true,
      "explanation": "The quote appears in the first paragraph of the document, though with some minor OCR artifacts: 'manufacturing process can lead to egg adapted mutations in themagglutinin (HA) protein in IIV, that could result in altered an ...iff i (VE) i h i l i'. Despite the artifacts, the semantic content matches the provided quote: the manufacturing process can lead to egg-adapted mutations in the HA protein in inactivated influenza vaccine (IIV), which could result in altered antigenicity and reduced vaccine effectiveness (VE) in the population.. The quote directly supports the claim. It explicitly states that the manufacturing process (specifically for egg-based vaccines) can lead to egg-adapted mutations in the hemagglutinin (HA) protein, which could result in altered antigenicity and reduced vaccine effectiveness. This matches the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness. The quote does not mention cell-based vaccines developing mutations, but it does substantiate the risk for egg-based vaccines as described in the claim.",
      "presence_explanation": "The quote appears in the first paragraph of the document, though with some minor OCR artifacts: 'manufacturing process can lead to egg adapted mutations in themagglutinin (HA) protein in IIV, that could result in altered an ...iff i (VE) i h i l i'. Despite the artifacts, the semantic content matches the provided quote: the manufacturing process can lead to egg-adapted mutations in the HA protein in inactivated influenza vaccine (IIV), which could result in altered antigenicity and reduced vaccine effectiveness (VE) in the population.",
      "support_explanation": "The quote directly supports the claim. It explicitly states that the manufacturing process (specifically for egg-based vaccines) can lead to egg-adapted mutations in the hemagglutinin (HA) protein, which could result in altered antigenicity and reduced vaccine effectiveness. This matches the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness. The quote does not mention cell-based vaccines developing mutations, but it does substantiate the risk for egg-based vaccines as described in the claim.",
      "original_relevance": "This quote directly states that the manufacturing process for egg-based vaccines can cause mutations in the HA protein, which may change the antigenic properties of the vaccine and reduce its effectiveness, supporting the claim."
    },
    {
      "id": 2,
      "quote": "Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epitopes and reduce immunogenicity to circulating viruses.",
      "supports_claim": true,
      "explanation": "The quote 'Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epitopes and reduce immunogenicity to circulating viruses.' appears in the document, specifically in the author list and summary section on page 1. The wording and meaning are preserved, with only minor formatting differences (e.g., 'immunogenicity' instead of 'immunogen i city', 'epitopes' instead of 'epi to pes'). The factual content is identical.. The quote directly supports the claim. It states that repeat vaccination with egg-based influenza vaccines can preferentially boost antibodies to egg-adapted (mutated) epitopes, which are not present on circulating viruses, and this can reduce immunogenicity (immune response) to the actual circulating viruses. This aligns with the claim that cell- and egg-based flu vaccines can develop mutations during production that may reduce their effectiveness.",
      "presence_explanation": "The quote 'Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epitopes and reduce immunogenicity to circulating viruses.' appears in the document, specifically in the author list and summary section on page 1. The wording and meaning are preserved, with only minor formatting differences (e.g., 'immunogenicity' instead of 'immunogen i city', 'epitopes' instead of 'epi to pes'). The factual content is identical.",
      "support_explanation": "The quote directly supports the claim. It states that repeat vaccination with egg-based influenza vaccines can preferentially boost antibodies to egg-adapted (mutated) epitopes, which are not present on circulating viruses, and this can reduce immunogenicity (immune response) to the actual circulating viruses. This aligns with the claim that cell- and egg-based flu vaccines can develop mutations during production that may reduce their effectiveness.",
      "original_relevance": "This quote explains that repeated use of egg-based vaccines can enhance immune responses to egg-adapted (mutated) epitopes rather than those found on circulating viruses, potentially reducing the vaccine's effectiveness."
    },
    {
      "id": 4,
      "quote": "Several studies have reported that Q223R egg adapted change at the HA head domain of A (H1N1) pdm09 virus can promote virus replication in eggs, alter antigenicity and influence immune response.",
      "supports_claim": true,
      "explanation": "The quote appears on page 9 of the document: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' The wording is nearly identical to the quote to verify, with only minor formatting differences (e.g., 'antigen i city' instead of 'antigenicity'). The factual content is preserved.. The quote directly supports the claim. It provides a specific example (Q223R mutation) that arises during egg-based production of the A (H1N1)pdm09 virus, and explicitly states that this mutation can alter antigenicity and influence immune response. This demonstrates that mutations can occur during production and may reduce vaccine effectiveness, thus supporting the claim.",
      "presence_explanation": "The quote appears on page 9 of the document: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' The wording is nearly identical to the quote to verify, with only minor formatting differences (e.g., 'antigen i city' instead of 'antigenicity'). The factual content is preserved.",
      "support_explanation": "The quote directly supports the claim. It provides a specific example (Q223R mutation) that arises during egg-based production of the A (H1N1)pdm09 virus, and explicitly states that this mutation can alter antigenicity and influence immune response. This demonstrates that mutations can occur during production and may reduce vaccine effectiveness, thus supporting the claim.",
      "original_relevance": "This quote provides a specific example of a mutation (Q223R) that occurs during egg-based production, which alters the antigenic properties of the virus and can affect the immune response, supporting the claim."
    },
    {
      "id": "comp_2",
      "quote": "Several studies have reported that Q223R egg adapted change at the HA head domain of A (H1N1) pdm09 virus can promote virus replication in eggs, alter antigenicity and influence immune response 37 42.",
      "supports_claim": true,
      "explanation": "The quote appears on page 9 of the document as: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' This matches the factual content of the quote to verify, with only minor formatting differences (e.g., 'Q223R' vs 'Q223 R', 'antigenicity' vs 'antigen i city'). The meaning and technical content are preserved.. The quote directly states that the Q223R egg-adapted change (a mutation) at the HA head domain of A(H1N1)pdm09 virus can arise during egg-based vaccine production, and that it can alter antigenicity and influence immune response. This supports the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness, since changes in antigenicity and immune response are mechanisms by which effectiveness can be reduced.",
      "presence_explanation": "The quote appears on page 9 of the document as: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' This matches the factual content of the quote to verify, with only minor formatting differences (e.g., 'Q223R' vs 'Q223 R', 'antigenicity' vs 'antigen i city'). The meaning and technical content are preserved.",
      "support_explanation": "The quote directly states that the Q223R egg-adapted change (a mutation) at the HA head domain of A(H1N1)pdm09 virus can arise during egg-based vaccine production, and that it can alter antigenicity and influence immune response. This supports the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness, since changes in antigenicity and immune response are mechanisms by which effectiveness can be reduced.",
      "original_relevance": "This quote provides evidence from multiple studies that specific mutations (such as Q223R) can arise during egg-based vaccine production, affecting antigenicity and immune response, which supports the claim about mutation-induced reduced effectiveness."
    }
  ],
  "verification_stats": {
    "total_verified": 4
  },
  "image_evidence": [
    {
      "image_filename": "table_p3_det_2_003.png",
      "image_path": "Liu_et_al.__2024_/extracted/figures/table_p3_det_2_003.png",
      "image_type": "Table",
      "page_number": 3,
      "block_id": "det_2_003",
      "claim_id": "claim_002",
      "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
      "supports_claim": true,
      "explanation": "A multi-part table comparing amino acid sequences of hemagglutinin from cell-based versus egg-based influenza vaccine viruses across multiple strains (A/H1N1, A/H3N2, B/Victoria, B/Yamagata). Specific HA positions (e.g., 91, 121, 128, etc.) are listed as columns. Rows show the amino acids in cell-grown vaccine seed viruses and corresponding egg-grown candidate vaccine viruses (CVVs). Egg-adapted substitutions are highlighted in bold/italic and glycosylation motif losses are marked \u201c(CHO-)\u201d. Evidence: Multiple egg-based vaccine viruses (e.g., A/Singapore/INFIMH-16-0019/2016 egg CVV, A/Kansas/14/2017 egg) display egg-adapted amino acid substitutions (italic/bold) and glycosylation motif losses (CHO-), which are absent in the cell-based counterparts. The table supports the claim by directly demonstrating that egg-based vaccine strains acquire specific HA mutations (including glycosylation motif losses) during production, which could alter antigenicity and potentially reduce vaccine effectiveness, thus supports the claim.",
      "model_used": "o4-mini",
      "detailed_analysis": {
        "supports_claim": true,
        "image_description": "A multi-part table comparing amino acid sequences of hemagglutinin from cell-based versus egg-based influenza vaccine viruses across multiple strains (A/H1N1, A/H3N2, B/Victoria, B/Yamagata). Specific HA positions (e.g., 91, 121, 128, etc.) are listed as columns. Rows show the amino acids in cell-grown vaccine seed viruses and corresponding egg-grown candidate vaccine viruses (CVVs). Egg-adapted substitutions are highlighted in bold/italic and glycosylation motif losses are marked \u201c(CHO-)\u201d.",
        "evidence_found": "Multiple egg-based vaccine viruses (e.g., A/Singapore/INFIMH-16-0019/2016 egg CVV, A/Kansas/14/2017 egg) display egg-adapted amino acid substitutions (italic/bold) and glycosylation motif losses (CHO-), which are absent in the cell-based counterparts.",
        "reasoning": "The table supports the claim by directly demonstrating that egg-based vaccine strains acquire specific HA mutations (including glycosylation motif losses) during production, which could alter antigenicity and potentially reduce vaccine effectiveness, thus supports the claim.",
        "confidence_notes": null
      }
    },
    {
      "image_filename": "figure_p9_det_8_005.png",
      "image_path": "Liu_et_al.__2024_/extracted/figures/figure_p9_det_8_005.png",
      "image_type": "Figure",
      "page_number": 9,
      "block_id": "det_8_005",
      "claim_id": "claim_002",
      "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
      "supports_claim": true,
      "explanation": "Two-panel line graph showing, for age groups 18\u201344 years (A) and 45\u201364 years (B), the proportion of participants in seven repeat\u2010vaccination arms with \u22654\u2010fold reduced hemagglutination inhibition (HI) titer against cell\u2010grown vaccine virus (egg/cell titer ratio \u22654) before and one month after Year 2 vaccination. Results are shown for four vaccine components (A(H3N2), A(H1N1)pdm09, B/Victoria, B/Yamagata) with p-values for significant pre-to-post increases noted on trend lines. Seven vaccine arms (egg- and cell-based and recombinant combinations) are distinguished by different symbols and colors. Evidence: Significant increases in the proportion of participants with \u22654-fold reduced HI titer to cell-grown virus after vaccination for egg-based components (A(H1N1)pdm09 p=0.02, B/Victoria p=0.03 in 18\u201344 years; A(H3N2) p=0.04 in 45\u201364 years), indicating egg-adaptation mutations that reduce antibody recognition. The figure demonstrates that egg-based vaccine viruses acquire egg-adaptive mutations that lead to significantly reduced HI titers against the corresponding cell-grown virus, which supports the claim by showing production\u2010related mutations that can reduce vaccine effectiveness. Note: Some text and symbols are small and may be difficult to read, but key p-values and trends are legible.",
      "model_used": "o4-mini",
      "detailed_analysis": {
        "supports_claim": true,
        "image_description": "Two-panel line graph showing, for age groups 18\u201344 years (A) and 45\u201364 years (B), the proportion of participants in seven repeat\u2010vaccination arms with \u22654\u2010fold reduced hemagglutination inhibition (HI) titer against cell\u2010grown vaccine virus (egg/cell titer ratio \u22654) before and one month after Year 2 vaccination. Results are shown for four vaccine components (A(H3N2), A(H1N1)pdm09, B/Victoria, B/Yamagata) with p-values for significant pre-to-post increases noted on trend lines. Seven vaccine arms (egg- and cell-based and recombinant combinations) are distinguished by different symbols and colors.",
        "evidence_found": "Significant increases in the proportion of participants with \u22654-fold reduced HI titer to cell-grown virus after vaccination for egg-based components (A(H1N1)pdm09 p=0.02, B/Victoria p=0.03 in 18\u201344 years; A(H3N2) p=0.04 in 45\u201364 years), indicating egg-adaptation mutations that reduce antibody recognition.",
        "reasoning": "The figure demonstrates that egg-based vaccine viruses acquire egg-adaptive mutations that lead to significantly reduced HI titers against the corresponding cell-grown virus, which supports the claim by showing production\u2010related mutations that can reduce vaccine effectiveness.",
        "confidence_notes": "Some text and symbols are small and may be difficult to read, but key p-values and trends are legible."
      }
    }
  ]
}